文献速递基础与转化研究流行病学与生物统计

肾移植受者无种族估算肾小球滤过率方程的开发与验证研究

Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study.
PubMed 文献 · BMJ · 2023-05-31

本研究基于欧洲、美国、澳大利亚17个队列共15489例成人肾移植受者,开发并验证了一种基于肌酐、年龄和性别的无种族肾移植受者特异性GFR方程。该方程在外部验证队列中表现良好(P30 73.0%至91.3%),优于无种族CKD-EPI 2021方程。

要点

  • 新开发的无种族肾移植受者特异性GFR方程在外部验证队列中P30为73.0%至91.3%。
  • 无种族CKD-EPI 2021方程在现有方程中表现最低。
  • 将种族纳入肾移植受者特异性方程未提高性能。

核心结论

  • 开发并验证了一种新的无种族肾移植受者特异性GFR方程,该方程在多个大型国际肾移植受者队列中显示出高准确性,且优于在原生肾脏个体中开发的无种族CKD-EPI 2021方程。

研究设计与样本

  • 开发与验证研究,设置于欧洲、美国、澳大利亚的17个队列(14个移植中心、3项临床试验)。
  • 纳入15489名成人肾移植受者,移植时间在2000年1月1日至2021年1月1日之间;开发队列3622例(法国Necker、Saint Louis和Toulouse医院),外部验证队列共11867例。
  • 主要结局指标为按当地实践测量的GFR;使用P30(eGFR在mGFR的30%以内的比例)和正确分类(根据GFR分期eGFR与mGFR的一致性)评估方程性能。
  • 无种族方程基于肌酐水平、年龄和性别,采用加性和乘性线性回归开发,并与MDRD方程、CKD-EPI 2009方程和无种族CKD-EPI 2021方程比较。
  • 试验注册号:ClinicalTrials.gov NCT05229939。

主要发现

  • 研究纳入15489名参与者,共有50464个mGFR和eGFR值。
  • 开发队列平均GFR为53.18 mL/min/1.73m2(SD 17.23),外部验证队列为55.90 mL/min/1.73m2(SD 19.69)。
  • 在现有GFR方程中,无种族CKD-EPI 2021方程相比MDRD和CKD-EPI 2009方程表现最低。
  • 将种族纳入肾移植受者特异性GFR方程时,性能未提高。
  • 无种族肾移植受者特异性GFR方程相比无种族CKD-EPI 2021方程性能显著改善,并在外部验证队列中表现良好(P30范围为73.0%至91.3%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the performance of a newly developed race-free kidney recipient specific glomerular filtration rate (GFR) equation with the three current main equations for measuring GFR in kidney transplant recipients. DESIGN: Development and validation study SETTING: 17 cohorts in Europe, the United States, and Australia (14 transplant centres, three clinical trials). PARTICIPANTS: 15 489 adults (3622 in development cohort (Necker, Saint Louis, and Toulouse hospitals, France), 11 867 in multiple external validation cohorts) who received kidney transplants between 1 January 2000 and 1 January 2021. MAIN OUTCOME MEASURE: The main outcome measure was GFR, measured according to local practice. Performance of the GFR equations was assessed using P30 (proportion of estimated GFR (eGFR) within 30% of measured GFR (mGFR)) and correct classification (agreement between eGFR and mGFR according to GFR stages). The race-free equation, based on creatinine level, age, and sex, was developed using additive and multiplicative linear regressions, and its performance was compared with the three current main GFR equations: Modification of Diet in Renal Disease (MDRD) equation, Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2009 equation, and race-free CKD-EPI 2021 equation. RESULTS: The study included 15 489 participants, with 50 464 mGFR and eGFR values. The mean GFR was 53.18 mL/min/1.73m2 (SD 17.23) in the development cohort and 55.90 mL/min/1.73m2 (19.69) in the external validation cohorts. Among the current GFR equations, the race-free CKD-EPI 2021 equation showed the lowest performance compared with the MDRD and CKD-EPI 2009 equations. When race was included in the kidney recipient specific GFR equation, performance did not increase. The race-free kidney recipient specific GFR equation showed significantly improved performance compared with the race-free CKD-EPI 2021 equation and performed well in the external validation cohorts (P30 ranging from 73.0% to 91.3%). The race-free kidney recipient specific GFR equation performed well in several subpopulations of kidney transplant recipients stratified by race (P30 73.0-91.3%), sex (72.7-91.4%), age (70.3-92.0%), body mass index (64.5-100%), donor type (58.5-92.9%), donor age (68.3-94.3%), treatment (78.5-85.2%), creatinine level (72.8-91.3%), GFR measurement method (73.0-91.3%), and timing of GFR measurement post-transplant (72.9-95.5%). An online application was developed that estimates GFR based on recipient's creatinine level, age, and sex (https://transplant-prediction-system.shinyapps.io/eGFR_equation_KTX/). CONCLUSION: A new race-free kidney recipient specific GFR equation was developed and validated using multiple, large, international cohorts of kidney transplant recipients. The equation showed high accuracy and outperformed the race-free CKD-EPI 2021 equation that was developed in individuals with native kidneys. TRIAL REGISTRATION: ClinicalTrials.gov NCT05229939.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Raynaud M, Al-Awadhi S, Juric I, et al. Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study. BMJ. 2023. PMID: 37257905. doi:10.1136/bmj-2022-073654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。